@the_news_21
National Technical Advisory Group on Immunization (NTAGI) has approved Serum Institute of India’s COVID-19 vaccine Covovax for the 12-17 age group, sources told news agency ANI.
Last month, an expert panel of the country’s central drug authority recommended granting emergency use authorisation (EUA) to Covovax for the 12-17 age group.
Stay Ahead with Independent Journalism
Investigations, political analysis and major national and global stories delivered directly to your inbox.
TheNews21 is India’s independent digital news and investigative journalism platform founded by senior journalist Vivek Bhavsar. From its Mumbai newsroom, it reports on governance, politics, public policy, business and international affairs, while publishing in-depth investigative stories in the public interest.
